DGAP-News: Evotec SE / Key word(s): Miscellaneous 08.07.2019 / 07:30 The issuer is solely responsible for the content of this announcement. PORTFOLIO OF DRUG DISCOVERY PROJECTS TARGETING DNA DAMAGE RESPONSES (“DDR”), A HIGHLY PROMISING APPROACH TO TREAT CANCER PATIENTS BREAKPOINT … Continue reading